The UK-based pharmaceutical maker’s two-shot solution appears to be even more efficacious against symptomatic infection than Johnson & Johnson’s one-dose injection.
The UK-based pharmaceutical maker’s two-shot solution appears to be even more efficacious against symptomatic infection than Johnson & Johnson’s one-dose injection.